生命科学资讯

Thermo Fisher Scientific launches CorEvitas Clinical Registry for rare autoimmune disorder - scientistlive.com

AMPK modulates a DEAH box RNA-helicase to attenuate TOR signaling and establish developmental quiescence in Caenorhabditis elegans

Glia-to-glia serotonin signaling directs MMP-dependent infiltration for experience-dependent synapse pruning

Expression of Concern: Lipoprotein Receptor LRP1 Regulates Leptin Signaling and Energy Homeostasis in the Adult Central Nervous System

Divergent and stabilizing selection shape the phenotypic space of Arabidopsis thaliana

A dynamic spatiotemporal normalization model captures perceptual and neural effects of spatial and temporal context

Holiday notice

Biopharma Sentiment Index | Q4 2025

"Heavy AI" is taking over biopharma | Signal Pulse Report

Introducing Endpoints Signal — intelligence for fresh biopharma insights

Belite continues ascent as Stargardt drug hits mark in late-stage trial

Agilent Announces 21 Cfr Part 11 Compliance Software For Xcelligence RTCA eSight - TradingView

Agilent Technologies, Inc. $A Shares Sold by Groupama Asset Managment - MarketBeat

A drugmaker charts a path through pharma’s ethical minefields

YuviTal wins Roche-backed breast cancer innovation challenge - JNS.org

Mackenzie Financial Corp Cuts Position in Agilent Technologies, Inc. $A - MarketBeat

Protego plans pivotal trial for AL amyloidosis prospect with $130M series B

Gene writing startup Tessera strikes $150M partnership with Regeneron

Protego gets $130M for AL amyloidosis drug from leaders behind Vyndaqel

Generate:Biomedicines to start Phase 3 studies for TSLP antibody